http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201219384-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-02 |
| filingDate | 2010-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6155a3ddb46a7d2251fd657c1995bd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c742b88020e583bc50b9ddece695944b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b3ded1eee189c7b092fecc9a006948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b612613ae0a9f1a947af6a0f5edc795 |
| publicationDate | 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201219384-A |
| titleOfInvention | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings |
| abstract | The present invention relates to a pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings, wherein the pharmaceutical composition contains (3aS, 5s, 6aR)-5-(2-((2S, 4S)-2-cyano-4-fluoropyrrolidine-1-yl)-2-oxo-ethylamino)-N, N, 5-trimethyl-hexahydro-cyclopenta[C]pyrrole-2(1H)-carboxamide or its pharmaceutically acceptable salts and rosiglitazone or pioglitazone or their pharmaceutically acceptable salts, preparation method thereof and a method of treating 2 type diabetes in mammals including human beings with the composition. |
| priorityDate | 2010-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.